The African Development Bank Group has formally introduced its new initiative that will join hands with the African Union to boost Africa’s capacity to produce drugs, vaccines, diagnostics, and therapeutics all along the value chain, to help build its pharmaceutical sector.
The African Pharmaceutical Technology Foundation (APTF) was the focus of a forum hosted by the African Development Bank under the theme: “Technology Access for Pharmaceutical Manufacturing: The African Pharmaceutical Technology Foundation.” The event was part of the 2nd International Conference on Public Health in Africa in Kigali, Rwanda, on 14 December.
According to the African Development Bank, the continent imports more than 70% of the medicines it needs at the cost of $14 billion annually. Changing the game to enable African countries develop their capacity to manufacture pharmaceutical products has public health, strategic and economic rationales.
“This new initiative comes as a solution, since most [African] countries still face challenges in receiving [medicines] on time,” Dr. Yvan Butera, Rwandan Minister of State for Health, commented. The Foundation, hosted by the Government of Rwanda in Kigali, is expected to commence operations in early 2023.
In his opening remarks, Mr. Solomon Quaynor, Vice-President for Private Sector, Infrastructure and Industrialisation at the African Development Bank Group, said Covid-19 had exposed the gaps in Africa’s health care system.
“The Covid-19 pandemic has exposed the fragility of global health systems and the gaps in the production of critical drugs on the continent.” He added: “The APTF is a ground-breaking institution that will significantly enhance Africa’s access to technologies that underpin the manufacturing of pharmaceutical products.”
Presenting the APTF at the event, Prof. Padmashree Gehl Sampath, Special Adviser on pharmaceuticals and health infrastructure to Dr. Akinwumi Adesina, President of the African Development Bank Group, stressed that the Foundation was designed to help African countries bridge the technology gaps in sustainable domestic manufacturing.
Prof. Sampath said: “Pharmaceutical companies in Africa have three specific impediments to technology access: access to technology and related know-how for production, mobilization of domestic resources for technological upgrading, and the lack of possibilities for horizontal and vertical product diversification. Many technological risks need to be indemnified to build Africa’s pharmaceutical sector, including shifting away from a product-by-product approach which puts African companies at risk.”
The co-chair of the International Negotiating Body of the World Health Organization (WHO) on Pandemic Prevention, Preparedness and Response, Dr. Precious Matsoso, reflected on how important technology issues are for future pandemic preparation. She said establishing the African Pharmaceutical Technology Foundation “would provide the much-needed support to address technology barriers for equitable access.”
Describing the establishment of the Foundation as “timely,” given the experience of Covid-19, Dr. Richard Hatchett, Chief Executive Officer of the Coalition of Epidemic Preparedness Initiative, stressed that the initiative “will help in saving lives on the continent”.
The Foundation, approved by the African Development Bank’s Board of Directors in June 2022, is expected to boost Africa’s access to technology for manufacturing the full range of pharmaceutical products, focusing on building supply chains and expanding access to building block technologies of various kinds.
The Foundation will also serve as a transparent intermediator advancing and brokering the interests of the African pharmaceutical sector on the global stage, to enhance access to proprietary technologies, know-how, and related industrial processes, through licensing and other market-based and non-market mechanisms.
The WHO, the Coalition on Epidemic Preparedness, the South Centre, Geneva, and the Federal Ministry for Economic Cooperation and Development of Germany have expressed keen interest in working with the Foundation in the coming year.
Another panelist, Prof. Carlos Correa, Executive Director of South Centre, Geneva, said it was important for Africa to have its own framework that will allow its pharmaceutical industry to develop. He said: “Intellectual property confers monopolies, and these monopolies give rights to property owners to control the sharing of technologies. Creating the capacity to facilitate timely technology transfer to Africa is important.”
Panelists stressed the need to establish partnerships between African pharmaceutical companies and their counterparts in other continents, such as Europe.
Brigit Pickel, the Director General for Africa in the Germany Federal Ministry for Economic Cooperation and Development, said Covid-19 brought the focus back on how local manufacturing of crucial health products can be improved. Germany welcomes the setting up of the APTF and its vital role in addressing the bottlenecks in the technology and the market development side, she added.
Prof. Fredrick Abbott, Edward Ball Eminent Scholar, Florida State University, USA, spoke about how to truly create a successful pharmaceutical sector: “You need a focus on intellectual property management in the broad sense of the word…there also needs to be a focus on promoting joint ventures such as those that have facilitated the creation of many Covid-19 vaccines.”
Source: afdb.org
Share this news
This Year’s Most Read News Stories
Tanzania Declares Marburg Outbreak – Africa CDC Mobilizes Immediate Response
Addis Ababa, January 20, 2025</Strong> — Tanzania has declared a Marburg virus disease (MVD) outbreak after confirming one case and identifying 25 suspected cases in the Kagera Region of Northwestern Tanzania. The Marburg virus, a highly infectious and often fatal disease, is similar to Ebola and is transmitted to humans from fruit bats and monkeys. This outbreak marks the nation’s second encounter with the deadly virus, following the outbreak in Bukoba District of Kagera Region in March 2023, which resulted in nine cases and six deaths.
In response to this urgent threat, the Africa CDC is mobilizing strong support to help Tanzania contain the outbreak. A team of twelve public health experts will be deployed as part of an advance mission in the next 24 hours. The multidisciplinary team includes epidemiologists, risk communication, infection prevention and control (IPC), and laboratory experts to provide on-ground support for surveillance, IPC, diagnostics, and community engagement.
The Director-General of Africa CDC, Dr. Jean Kaseya, has engaged with Tanzania’s President Samia Suluhu Hassan and the Minister of Health to ensure coordinated efforts and secure political commitment for the response.
“Africa CDC stands firmly with Tanzania in this critical moment. To support the government’s efforts, we are committing US$ 2 million to bolster immediate response measures, including deploying public health experts, strengthening diagnostics, and enhancing case management. Building on Tanzania’s commendable response during the 2023 outbreak, we are confident that swift and decisive action, combined with our support and those of other partners, will bring this outbreak under control,” Dr. Kaseya stated.
Africa CDC has recently supported efforts to enhance the diagnostic and sequencing capacity of public health laboratories in Tanzania. PCR Test kits and genomic sequencing reagents have been dispatched, with additional supplies in the pipeline. To ensure rapid identification and confirmation of cases, the institution will also provide technical assistance to strengthen detection and genome sequencing for better characterization of the pathogen. Additionally, support will be provided to improve case management protocols and enhance the capacity to deliver safe and effective treatment.
Africa CDC is committed to working closely with the Government of Tanzania, regional partners, international organizations, and global stakeholders, including the World Health Organization, to stop the spread of the Marburg virus.
Source: allafrica.com
East African Community Bloc Dismisses Fake Common Currency
The secretariat of the East African Community (EAC) regional bloc has dismissed a post on X, formerly Twitter, which claimed that the bloc’s member countries have launched a common regional currency.Continue Reading
Zanzibar terminates land lease offered to British developer
The Revolutionary Government of Zanzibar (SMZ) has terminated a land lease held by British property developer Pennyroyal Limited in Matemwe, the developer has announced.Continue Reading
